Please login to the form below

Not currently logged in
Email:
Password:

global

This page shows the latest global news and features for those working in and with pharma, biotech and healthcare.

CDM develops creative global collaboration model

CDM develops creative global collaboration model

CDM develops creative global collaboration model. The healthcare advertising agency will offers a global collaborative approach from its base in the UK capital. ... CDM has promoted creative director Olly Caporn into a new global role as the healthcare

Latest news

  • PharmaLex strikes up AI collaboration with Volv PharmaLex strikes up AI collaboration with Volv

    Development consulting and affairs group PharmaLex has teamed up with privately held Volv Global to bolster its pharmacovigilance business. ... Christopher Rudolf, founder and chief executive officer of Volv Global, said: “We are delighted to be

  • Havas Group acquires SO What Global Havas Group acquires SO What Global

    Havas Group acquires SO What Global. Founders Scott Clark and Oliver Parsons will continue to lead the SO team. ... Havas Group has acquired UK-based communications agency So What Global, which will join its Havas Health &You unit under the name Havas SO.

  • Dr Bug mobile game introduces kids to antibiotics, bacteria and viruses Dr Bug mobile game introduces kids to antibiotics, bacteria and viruses

    The not-for-profit app is a collaboration between Oxford PharmaGenesis and Global Initiative. ... HealthScience communications consultancy Oxford PharmaGenesis has partnered up with digital developer Global Initiative to create an educational,

  • Sermo reaches 150,000 members after global expansion drive Sermo reaches 150,000 members after global expansion drive

    Sermo reaches 150, 000 members after global expansion drive. Online physician community now has doors open in more than 150 new countries. ... Sermo now has its virtual doors open in more than 150 countries after an expansion drive that saw members of

  • Sanofi buys into AZ drug for preventing RSV infections Sanofi buys into AZ drug for preventing RSV infections

    As a global leader in the paediatric vaccine industry, this deal with MedImmune therefore makes perfect sense for Sanofi Pasteur.". ... potential to reduce global infant mortality.

More from news
Approximately 25 fully matching, plus 1,080 partially matching documents found.

Latest Intelligence

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    This global research, looking at 13, 000 patients across 66 countries, found that over 12% of those undergoing procedures developed a post-operative surgical site infection (SSI). ... market. About the AMR Centre. The AMR Centre is a key part of the

  • Brexit Means Brexit Brexit Means Brexit

    It’s always helpful to get professional advice from regulatory professionals that are well-versed in the dynamics of global regulation and can provide the holistic view, ”says Jonathan.

  • A critical juncture for clinical data management A critical juncture for clinical data management

    A critical juncture for clinical data management. Data management functions are handling a much higher volume and diversity of data in response to the increasing scope and demands of global drug

  • A new era of smart pharma A new era of smart pharma

    According to the McKinsey Global Institute, it is estimated that, by applying big data strategies to better inform decision-making, the United States could generate up to $100bn in value annually ... The McKinsey Global Institute expects that, within

  • The Patient Safety Challenge The Patient Safety Challenge

    Harm reduction as a global goal. In response to the challenge of improving patient safety and reducing harm, the World Health Organization (WHO) published Medication Without Harm, WHO Global Patient Safety ... Ultimately, we need to research if these

More from intelligence
Approximately 1 fully matching, plus 413 partially matching documents found.

Latest appointments

  • Abeona Therapeutics names CEO Abeona Therapeutics names CEO

    Steven Rouhandeh, executive chairman of Abeona, said: “As CEO, Carsten Thiel brings a unique combination of extensive experience in research and global rare disease commercialisation to Abeona.

  • Sobi poaches Pfizer’s Fredrick Wetterlundh Sobi poaches Pfizer’s Fredrick Wetterlundh

    Joining from pharma giant Pfizer, Wetterlundh most recently held the position of global human resources lead, gaining extensive experience in leading business-driven HR organisations, processes and projects in Asia, Europe, ... supporting our

  • Smith & Nephew name new CEO Smith & Nephew name new CEO

    Global medical technology business Smith &Nephew has named Namal Nawana as its new chief executive officer.

  • emotive bolsters client services team emotive bolsters client services team

    Lilienthal joins emotive from Chameleon Communications, an international healthcare consultancy where she led teams working on global accounts.

  • Neurocentrx appoints two members to the board Neurocentrx appoints two members to the board

    Brooksby brings experience in business and growth strategy across the healthcare sector having held senior global positions at Pfizer, Sanofi and Wellcome - now GSK. ... Brooksby said: “My focus is to accelerate the business model and drive commercial

More from appointments
Approximately 5 fully matching, plus 772 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 20 fully matching, plus 714 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics